S 25932

structure given in first source

Also Known As:

6,7-dihydro-9-fluoro-8-imidazolyl-5-methyl-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid; S-25932; 1H,5H-Benzo(ij)quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(1H-imidazol-1-yl)-5-methyl-1-oxo-

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolizines: 1
      - S 25932: 2

Related Diseases

Neoplasms (Cancer)

10/01/1988 - "Comparative in vitro activity of the two new 4-quinolones S-25930 and S-25932 against gram-positive bacteria isolated from cancer patients."
01/01/1987 - "In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients."
01/01/1987 - "The in vitro activity of S-25930 and S-25932, two new 4-quinolones, against 450 aerobic gram-negative organisms isolated from cancer patients was evaluated and compared with the activity of ciprofloxacin, enoxacin, difloxacin (A-56619), and A-56620. "

Related Drugs and Biologics

1.	4-Quinolones (4 Quinolones)
2.	ibafloxacin
3.	Enoxacin (AT 2266)
4.	Quinolones
5.	Ciprofloxacin (Cipro)
6.	difloxacin
7.	sarafloxacin